Neuraminidase inhibitors as potential anti-influenza drugs.
Bamford
M J
MJ
Department of Medicinal Chemistry, Glaxo Research & Development Ltd., Stevenage, Hertfordshire, UK.
D000998:Antiviral Agents / Q000737:chemistry / Q000494:pharmacology; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D004791:Enzyme Inhibitors / Q000737:chemistry* / Q000494:pharmacology / Q000627:therapeutic use; D006146:Guanidines; D015394:Molecular Structure; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D009975:Orthomyxoviridae / Q000187:drug effects* / Q000201:enzymology; D011714:Pyrans; D012794:Sialic Acids / Q000737:chemistry / Q000494:pharmacology; D053243:Zanamivir
D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D006146:Guanidines; D011714:Pyrans; D012794:Sialic Acids; D009439:Neuraminidase; D053243:Zanamivir